Investigation of Personalis, Inc.

Shareholder Alert: Robbins LLP Announces It Is Investigating the Officers and Directors of Personalis, Inc. (PSNL) on Behalf of Shareholders

April 28, 2020 (San Diego, CA & Menlo Park, CA) - Shareholder rights law firm Robbins LLP announces it is investigating Personalis, Inc. (NYSE: PSNL) for potential violations of federal securities laws pursuant to its June 2019 initial public offering ("IPO"). Personalis completed its IPO on June 20, 2019, offering shares at $17.00 and raising $140 million in gross proceeds. Four days after the IPO, Personalis stock was trading as high as $31.88 per share. However, by April 27, 2020, shares of Personalis closed at $10.31 per share, representing a decline of almost 40% from its IPO price and a decline of 67% from its record high of $31.88 per share. Personalis operates as a cancer genomics company worldwide

Send us a message for more information.

Additional Alerts for Shareholders

chalkboard with INVESTIGATION handwritten in chalk

RxSight, Inc. Class Action

Robbins LLP Informs RxSight, Inc. Stockholders that it is Investigating the Officers and Directors of RXST to Determine if They Breached Fiduciary Duties Owed to Shareholders

Read More »
Free!
Skip to content